FDA OKs Strides Italy plant; Cedarburg Hauser expands API facility; AstraZeneca unloading more real estate;

> Strides Arcolab said the FDA has signed off on a facility in Milan, Italy, allowing it to export its liquids, semi-solids, ointments and creams to the U.S. Release

> Cedarburg Hauser Pharmaceuticals says it will expand capacity by at least 20% at its active pharmaceutical ingredient (API) plant in Grafton, WI. Release

> ATMI and Medinstill have formed a joint venture to market and manufacture INTACT Filler technology for the biopharmaceutical industry. Item

> Kemwell Biopharma says it has a contract with a European company to provide development of a new biological product through commercial production, including fill and finish, at its new plant in Bangalore, India. Report

> Catalent Pharma Solutions will manufacture extended release capsules for Supernus Pharmaceuticals, using that company's drug delivery technology. Report

And Finally... AstraZeneca ($AZN) has put its two-building South Campus up for sale in Wilmington, DE, which includes such amenities as a hair salon, fitness center and dining room. Story